MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Crocs Company Profile (NASDAQ:CROX)

Consensus Ratings for Crocs (NASDAQ:CROX) (?)
Ratings Breakdown: 5 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $16.00 (9.59% upside)

Analysts' Ratings History for Crocs (NASDAQ:CROX)
Show:
DateFirmActionRatingPrice TargetActions
6/10/2015Piper JaffraySet Price TargetBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2015Piper JaffrayReiterated RatingOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2015B. RileyInitiated CoverageNeutral$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Piper JaffrayUpgradeNeutral -> Overweight$13.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015WunderlichBoost Price TargetBuy$15.50 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Piper JaffrayReiterated RatingNeutral -> Hold$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Sterne Agee CRTReiterated RatingPositive$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Standpoint ResearchDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015Piper JaffrayReiterated RatingNeutral$10.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2015Sterne Agee CRTReiterated RatingBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Sterne Agee CRTSet Price TargetBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015WunderlichLower Price TargetBuy$17.00 -> $15.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Monness Crespi & HardtLower Price TargetBuy$20.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Piper JaffrayDowngradeOverweight -> Neutral$18.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014Sterne Agee CRTUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2014Sterne Agee CRTUpgradeNeutral -> Buy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014Piper JaffrayLower Price Target$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014WunderlichReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2014Monness Crespi & HardtReiterated RatingBuy$22.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2014WunderlichInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2014Buckingham ResearchDowngradeBuy -> Neutral$20.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2014WedbushBoost Price TargetNeutral$15.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014CL KingUpgradeNeutral -> Strong-BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2014Buckingham ResearchInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2014Piper JaffrayUpgradeNeutral -> Overweight$16.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2014Piper JaffrayInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2014Monness Crespi & HardtUpgradeNeutral -> Buy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/31/2013Imperial CapitalBoost Price TargetIn-Line$14.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2013Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2013Sterne Agee CRTUpgradeUnderperform -> Neutral$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2013Goldman SachsReiterated RatingNeutral$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2013Ned Davis ResearchUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2013Stifel NicolausReiterated RatingBuy$17.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/31/2013Imperial CapitalDowngradeOutperform -> In-Line$17.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2013Piper JaffrayDowngradeOverweight -> Neutral$18.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2013Sterne Agee CRTDowngradeNeutral -> Underperform$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2013Stifel NicolausReiterated RatingBuy$18.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2013Monness Crespi & HardtDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2013CL KingDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2013Goldman SachsDowngradeBuy -> Neutral$19.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2013WedbushDowngradeOutperform -> Neutral$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2013Ned Davis ResearchUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/6/2013 forward)